MX2010005999A - Intermediarios en la sintesis de analogos de macrolidos de zearalenona. - Google Patents
Intermediarios en la sintesis de analogos de macrolidos de zearalenona.Info
- Publication number
- MX2010005999A MX2010005999A MX2010005999A MX2010005999A MX2010005999A MX 2010005999 A MX2010005999 A MX 2010005999A MX 2010005999 A MX2010005999 A MX 2010005999A MX 2010005999 A MX2010005999 A MX 2010005999A MX 2010005999 A MX2010005999 A MX 2010005999A
- Authority
- MX
- Mexico
- Prior art keywords
- intermediates
- synthesis
- zearalenone
- macrolide analogs
- analogs
- Prior art date
Links
- 239000000543 intermediate Substances 0.000 title abstract 2
- 239000003120 macrolide antibiotic agent Substances 0.000 title abstract 2
- 230000015572 biosynthetic process Effects 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
- MBMQEIFVQACCCH-UHFFFAOYSA-N trans-Zearalenon Natural products O=C1OC(C)CCCC(=O)CCCC=CC2=CC(O)=CC(O)=C21 MBMQEIFVQACCCH-UHFFFAOYSA-N 0.000 title 1
- MBMQEIFVQACCCH-QBODLPLBSA-N zearalenone Chemical compound O=C1O[C@@H](C)CCCC(=O)CCC\C=C\C2=CC(O)=CC(O)=C21 MBMQEIFVQACCCH-QBODLPLBSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229940041033 macrolides Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
- C07D317/22—Radicals substituted by singly bound oxygen or sulfur atoms etherified
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
- C07D317/24—Radicals substituted by singly bound oxygen or sulfur atoms esterified
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D317/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
- C07D319/08—1,3-Dioxanes; Hydrogenated 1,3-dioxanes condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Cosmetics (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1241107P | 2007-12-07 | 2007-12-07 | |
| US1240907P | 2007-12-07 | 2007-12-07 | |
| US1240807P | 2007-12-07 | 2007-12-07 | |
| US8004808P | 2008-07-11 | 2008-07-11 | |
| PCT/US2008/013512 WO2009075823A1 (en) | 2007-12-07 | 2008-12-08 | Intermediates in the synthesis of zearalenone macrolide analogs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2010005999A true MX2010005999A (es) | 2010-06-23 |
Family
ID=40445478
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2010005999A MX2010005999A (es) | 2007-12-07 | 2008-12-08 | Intermediarios en la sintesis de analogos de macrolidos de zearalenona. |
| MX2010006091A MX2010006091A (es) | 2007-12-07 | 2008-12-08 | Intermediarios y metodos para hacer analogos de macrolido de zearalenona. |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2010006091A MX2010006091A (es) | 2007-12-07 | 2008-12-08 | Intermediarios y metodos para hacer analogos de macrolido de zearalenona. |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US8507696B2 (enExample) |
| EP (2) | EP2231634B1 (enExample) |
| JP (3) | JP5496908B2 (enExample) |
| CN (2) | CN101889005B (enExample) |
| BR (2) | BRPI0820953B1 (enExample) |
| CA (2) | CA2708141C (enExample) |
| IL (2) | IL205954A (enExample) |
| MX (2) | MX2010005999A (enExample) |
| RU (2) | RU2478630C2 (enExample) |
| WO (2) | WO2009075818A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7799827B2 (en) | 2002-03-08 | 2010-09-21 | Eisai Co., Ltd. | Macrocyclic compounds useful as pharmaceuticals |
| AU2008279027B8 (en) | 2007-07-25 | 2014-03-06 | Eisai R & D Management Co., Ltd. | Multikinase inhibitors for use in the treatment of cancer |
| JP5496908B2 (ja) * | 2007-12-07 | 2014-05-21 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | ゼラレノンマクロライドアナログを作製するための中間体および方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL69666A (en) * | 1982-09-13 | 1987-10-20 | Lilly Co Eli | 20-amino-20-deoxo-5-o-mycaminosyl-23-o-mycinosyltylonolide derivatives,their preparation and veterinary antibiotic use |
| GB9225396D0 (en) | 1992-12-04 | 1993-01-27 | Sandoz Ltd | Improvements in or relating to organic compounds |
| US5795910A (en) | 1994-10-28 | 1998-08-18 | Cor Therapeutics, Inc. | Method and compositions for inhibiting protein kinases |
| SK286592B6 (sk) * | 1997-07-08 | 2009-01-07 | Bristol-Myers Squibb Company | Derivát epotilónu, farmaceutický prostriedok s jeho obsahom a jeho použitie |
| JP2004292315A (ja) | 2000-12-14 | 2004-10-21 | Chugai Pharmaceut Co Ltd | Ｔａｋ１阻害剤 |
| JP2004292314A (ja) | 2000-12-14 | 2004-10-21 | Chugai Pharmaceut Co Ltd | ケラチノサイト増殖抑制剤 |
| US7915306B2 (en) | 2002-03-08 | 2011-03-29 | Eisai Co., Ltd. | Macrocyclic compounds useful as pharmaceuticals |
| US7799827B2 (en) * | 2002-03-08 | 2010-09-21 | Eisai Co., Ltd. | Macrocyclic compounds useful as pharmaceuticals |
| EP2136799B1 (en) | 2006-08-11 | 2017-10-04 | Universite De Strasbourg | Macrocyclic compounds useful as inhibitors of kinases and hsp90 |
| EP2173733A2 (en) * | 2007-06-05 | 2010-04-14 | WINSSINGER, Nicolas | Compositions and methods comprising analogues of radicicol a |
| AU2008279027B8 (en) * | 2007-07-25 | 2014-03-06 | Eisai R & D Management Co., Ltd. | Multikinase inhibitors for use in the treatment of cancer |
| TW200924749A (en) * | 2007-07-25 | 2009-06-16 | Eisai R & Amp D Man Co Ltd | Zearalenone macrolide derivatives and uses of the same |
| JP5496908B2 (ja) | 2007-12-07 | 2014-05-21 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | ゼラレノンマクロライドアナログを作製するための中間体および方法 |
-
2008
- 2008-12-08 JP JP2010536949A patent/JP5496908B2/ja active Active
- 2008-12-08 EP EP08860344.4A patent/EP2231634B1/en active Active
- 2008-12-08 WO PCT/US2008/013498 patent/WO2009075818A1/en not_active Ceased
- 2008-12-08 CA CA2708141A patent/CA2708141C/en active Active
- 2008-12-08 EP EP08860534.0A patent/EP2231635B1/en active Active
- 2008-12-08 RU RU2010128103/04A patent/RU2478630C2/ru active
- 2008-12-08 CN CN200880119543.8A patent/CN101889005B/zh active Active
- 2008-12-08 MX MX2010005999A patent/MX2010005999A/es active IP Right Grant
- 2008-12-08 JP JP2010536950A patent/JP5492786B2/ja active Active
- 2008-12-08 WO PCT/US2008/013512 patent/WO2009075823A1/en not_active Ceased
- 2008-12-08 CA CA2708143A patent/CA2708143C/en active Active
- 2008-12-08 MX MX2010006091A patent/MX2010006091A/es active IP Right Grant
- 2008-12-08 CN CN2008801195442A patent/CN101889006B/zh active Active
- 2008-12-08 US US12/746,675 patent/US8507696B2/en active Active
- 2008-12-08 US US12/746,672 patent/US8350059B2/en active Active
- 2008-12-08 BR BRPI0820953-7A patent/BRPI0820953B1/pt active IP Right Grant
- 2008-12-08 BR BRPI0820958-8A patent/BRPI0820958B1/pt active IP Right Grant
- 2008-12-08 RU RU2010128096/04A patent/RU2497803C2/ru active
-
2010
- 2010-05-25 IL IL205954A patent/IL205954A/en active IP Right Grant
- 2010-05-26 IL IL205983A patent/IL205983A/en active IP Right Grant
-
2013
- 2013-01-03 US US13/733,562 patent/US20130211103A1/en not_active Abandoned
-
2014
- 2014-03-05 JP JP2014042331A patent/JP2014141498A/ja not_active Withdrawn
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ588884A (en) | Cross-linkers and their uses | |
| TW200745149A (en) | Crystalline form of 1'-(1-methylethyl)-4'-[(2-fluoro-4-methoxyphenyl)methyl]-5'-methyl-1H-pyrazol-3'-O-β-D-glucopyranoside, a method for its preparation and the use thereof for preparing medicaments | |
| TW200800968A (en) | Sulfoximine-substituted pyrimidines, processes for production thereof and use thereof as drugs | |
| MX2010004234A (es) | Derivados de purina como ligandos del receptor de adenosina a1. | |
| MX2010003599A (es) | Intermediarios y metodos para la sintesis de analogos de halicondrina b. | |
| WO2009111653A3 (en) | Antiviral therapeutic agents | |
| AU2007249926A8 (en) | Monocyclic heteroaryl compounds | |
| MY151986A (en) | Adamantyl diamide derivatives and uses of same | |
| IL265947A (en) | Preparation of stansoporfin with a high degree of purification on a large scale | |
| EA017490B9 (ru) | 11-бета-гидроксиандроста-4-ен-3-оны | |
| GB0508318D0 (en) | Organic compounds | |
| TW200602347A (en) | Macrolides and methods for producing same | |
| TW200740814A (en) | Compounds | |
| GB0508314D0 (en) | Organic compounds | |
| WO2009062659A3 (en) | Polymorphs of enantiopure erdosteine | |
| MX2010006091A (es) | Intermediarios y metodos para hacer analogos de macrolido de zearalenona. | |
| TW200800986A (en) | Tetrahydroquinolines, synthesis thereof, and intermediates thereto | |
| MX2009009074A (es) | Macrolidos basados en eritromicina. | |
| TW200738713A (en) | Diazepinoquinolines, synthesis thereof, and intermediates thereto | |
| WO2008107771A3 (en) | 2',3'-di-o-acyl-5-fluoronucleosides | |
| MX2010003056A (es) | Polimorfos de valomaciclovir. | |
| ZA200903193B (en) | Novel Morphine derivatives | |
| WO2007098462A3 (en) | Trans-fused chromenoisoquinolines, synthesis and methods for use | |
| NZ593021A (en) | Method of preparing deoxyribofuranose compounds | |
| WO2011057192A3 (en) | Amphiphilic compositions and methods for preparing and using same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |